Life
Insilico Medicine's AI Integration Strategies in Drug Development
Alex Zhavoronkov, CEO of Insilico Medicine, outlines essential practices for effectively incorporating AI into drug development processes.
Editorial Staff 5 days ago
4 articles tagged with "Biotech"
Alex Zhavoronkov, CEO of Insilico Medicine, outlines essential practices for effectively incorporating AI into drug development processes.
Biogen's recent mid-stage study reveals promising results in skin clearance for lupus treatment, indicating potential advancements in therapeutic options for patients.
The ongoing discourse on drug pricing reveals contrasting strategies between the Trump and Biden administrations, with significant implications for the pharmaceutical infrastructure.
The FDA's recent approval of Leucovorin for a rare disorder, lacking conventional trial data, prompts a reevaluation of drug evaluation protocols and potential impacts on infrastructure.